nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—DHCR7—Epirubicin—thyroid cancer	0.186	0.247	CbGbCtD
Tamoxifen—FMO1—Vandetanib—thyroid cancer	0.18	0.239	CbGbCtD
Tamoxifen—FMO3—Vandetanib—thyroid cancer	0.112	0.149	CbGbCtD
Tamoxifen—DHCR7—Doxorubicin—thyroid cancer	0.0988	0.131	CbGbCtD
Tamoxifen—ABCG2—Vandetanib—thyroid cancer	0.0204	0.027	CbGbCtD
Tamoxifen—ABCB11—Doxorubicin—thyroid cancer	0.0157	0.0208	CbGbCtD
Tamoxifen—CYP1B1—Doxorubicin—thyroid cancer	0.0157	0.0208	CbGbCtD
Tamoxifen—ABCC2—Sorafenib—thyroid cancer	0.0136	0.018	CbGbCtD
Tamoxifen—ABCG2—Sorafenib—thyroid cancer	0.0123	0.0163	CbGbCtD
Tamoxifen—CYP3A7—Sorafenib—thyroid cancer	0.00906	0.012	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.00906	0.012	CbGbCtD
Tamoxifen—CYP2B6—Sorafenib—thyroid cancer	0.00863	0.0115	CbGbCtD
Tamoxifen—ABCC2—Doxorubicin—thyroid cancer	0.00823	0.0109	CbGbCtD
Tamoxifen—ABCG2—Doxorubicin—thyroid cancer	0.00744	0.00989	CbGbCtD
Tamoxifen—CYP3A5—Sorafenib—thyroid cancer	0.0068	0.00903	CbGbCtD
Tamoxifen—CYP2C8—Sorafenib—thyroid cancer	0.00653	0.00869	CbGbCtD
Tamoxifen—CES1—larynx—thyroid cancer	0.00549	0.106	CbGeAlD
Tamoxifen—CYP2C19—Sorafenib—thyroid cancer	0.00548	0.00729	CbGbCtD
Tamoxifen—CYP2B6—Doxorubicin—thyroid cancer	0.00523	0.00696	CbGbCtD
Tamoxifen—CYP1A2—Sorafenib—thyroid cancer	0.00506	0.00672	CbGbCtD
Tamoxifen—CYP2C9—Sorafenib—thyroid cancer	0.00456	0.00606	CbGbCtD
Tamoxifen—ABCB1—Sorafenib—thyroid cancer	0.00442	0.00588	CbGbCtD
Tamoxifen—CYP3A4—Vandetanib—thyroid cancer	0.0044	0.00584	CbGbCtD
Tamoxifen—CYP2D6—Sorafenib—thyroid cancer	0.00417	0.00554	CbGbCtD
Tamoxifen—SULT1A1—neck—thyroid cancer	0.003	0.0576	CbGeAlD
Tamoxifen—ABCB1—Doxorubicin—thyroid cancer	0.00268	0.00357	CbGbCtD
Tamoxifen—CYP3A4—Sorafenib—thyroid cancer	0.00265	0.00352	CbGbCtD
Tamoxifen—CYP2D6—Doxorubicin—thyroid cancer	0.00253	0.00336	CbGbCtD
Tamoxifen—SULT1A1—trachea—thyroid cancer	0.0018	0.0347	CbGeAlD
Tamoxifen—EBPL—thyroid gland—thyroid cancer	0.0018	0.0345	CbGeAlD
Tamoxifen—DHCR7—saliva-secreting gland—thyroid cancer	0.00166	0.032	CbGeAlD
Tamoxifen—ESRRA—saliva-secreting gland—thyroid cancer	0.00164	0.0315	CbGeAlD
Tamoxifen—CYP3A4—Doxorubicin—thyroid cancer	0.00161	0.00214	CbGbCtD
Tamoxifen—EBPL—head—thyroid cancer	0.00159	0.0306	CbGeAlD
Tamoxifen—CES1—neck—thyroid cancer	0.00146	0.028	CbGeAlD
Tamoxifen—SULT1A1—thyroid gland—thyroid cancer	0.00143	0.0274	CbGeAlD
Tamoxifen—DHCR7—trachea—thyroid cancer	0.00128	0.0247	CbGeAlD
Tamoxifen—FMO1—trachea—thyroid cancer	0.00128	0.0247	CbGeAlD
Tamoxifen—SULT1A1—head—thyroid cancer	0.00127	0.0243	CbGeAlD
Tamoxifen—ESRRA—trachea—thyroid cancer	0.00126	0.0243	CbGeAlD
Tamoxifen—ESR2—neck—thyroid cancer	0.00126	0.0242	CbGeAlD
Tamoxifen—EBPL—lymph node—thyroid cancer	0.00112	0.0215	CbGeAlD
Tamoxifen—DHCR7—thyroid gland—thyroid cancer	0.00102	0.0195	CbGeAlD
Tamoxifen—FMO1—thyroid gland—thyroid cancer	0.00102	0.0195	CbGeAlD
Tamoxifen—ESRRA—thyroid gland—thyroid cancer	0.000999	0.0192	CbGeAlD
Tamoxifen—DHCR7—head—thyroid cancer	0.000901	0.0173	CbGeAlD
Tamoxifen—FMO1—head—thyroid cancer	0.000901	0.0173	CbGeAlD
Tamoxifen—SULT1A1—lymph node—thyroid cancer	0.000887	0.017	CbGeAlD
Tamoxifen—ESRRA—head—thyroid cancer	0.000887	0.017	CbGeAlD
Tamoxifen—FMO3—thyroid gland—thyroid cancer	0.000877	0.0169	CbGeAlD
Tamoxifen—ESR1—neck—thyroid cancer	0.000863	0.0166	CbGeAlD
Tamoxifen—FMO3—head—thyroid cancer	0.000778	0.015	CbGeAlD
Tamoxifen—SIGMAR1—saliva-secreting gland—thyroid cancer	0.000762	0.0146	CbGeAlD
Tamoxifen—CES1—thyroid gland—thyroid cancer	0.000693	0.0133	CbGeAlD
Tamoxifen—FMO1—lymph node—thyroid cancer	0.000631	0.0121	CbGeAlD
Tamoxifen—DHCR7—lymph node—thyroid cancer	0.000631	0.0121	CbGeAlD
Tamoxifen—ESRRA—lymph node—thyroid cancer	0.000621	0.0119	CbGeAlD
Tamoxifen—CES1—head—thyroid cancer	0.000615	0.0118	CbGeAlD
Tamoxifen—ESR2—thyroid gland—thyroid cancer	0.0006	0.0115	CbGeAlD
Tamoxifen—SIGMAR1—trachea—thyroid cancer	0.000587	0.0113	CbGeAlD
Tamoxifen—FMO3—lymph node—thyroid cancer	0.000545	0.0105	CbGeAlD
Tamoxifen—ABCG2—saliva-secreting gland—thyroid cancer	0.000539	0.0104	CbGeAlD
Tamoxifen—ESR2—head—thyroid cancer	0.000532	0.0102	CbGeAlD
Tamoxifen—CYP19A1—thyroid gland—thyroid cancer	0.000473	0.00909	CbGeAlD
Tamoxifen—SIGMAR1—thyroid gland—thyroid cancer	0.000465	0.00893	CbGeAlD
Tamoxifen—CYP1B1—thyroid gland—thyroid cancer	0.000442	0.00849	CbGeAlD
Tamoxifen—CES1—lymph node—thyroid cancer	0.00043	0.00827	CbGeAlD
Tamoxifen—CYP19A1—head—thyroid cancer	0.000419	0.00806	CbGeAlD
Tamoxifen—ESR1—thyroid gland—thyroid cancer	0.000411	0.0079	CbGeAlD
Tamoxifen—CYP1A1—trachea—thyroid cancer	0.000395	0.00759	CbGeAlD
Tamoxifen—CYP1B1—head—thyroid cancer	0.000392	0.00754	CbGeAlD
Tamoxifen—ESR2—lymph node—thyroid cancer	0.000373	0.00716	CbGeAlD
Tamoxifen—ESR1—head—thyroid cancer	0.000364	0.00701	CbGeAlD
Tamoxifen—ABCG2—thyroid gland—thyroid cancer	0.000329	0.00633	CbGeAlD
Tamoxifen—CYP1A2—thyroid gland—thyroid cancer	0.000317	0.00609	CbGeAlD
Tamoxifen—CYP1A1—thyroid gland—thyroid cancer	0.000312	0.006	CbGeAlD
Tamoxifen—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000301	0.00242	CcSEcCtD
Tamoxifen—Fatigue—Vandetanib—thyroid cancer	0.0003	0.00241	CcSEcCtD
Tamoxifen—Constipation—Vandetanib—thyroid cancer	0.000298	0.00239	CcSEcCtD
Tamoxifen—Pain—Vandetanib—thyroid cancer	0.000298	0.00239	CcSEcCtD
Tamoxifen—Arrhythmia—Sorafenib—thyroid cancer	0.000296	0.00237	CcSEcCtD
Tamoxifen—CYP19A1—lymph node—thyroid cancer	0.000294	0.00564	CbGeAlD
Tamoxifen—Alopecia—Sorafenib—thyroid cancer	0.000292	0.00235	CcSEcCtD
Tamoxifen—Liver injury—Epirubicin—thyroid cancer	0.000289	0.00232	CcSEcCtD
Tamoxifen—SIGMAR1—lymph node—thyroid cancer	0.000289	0.00555	CbGeAlD
Tamoxifen—Erythema—Sorafenib—thyroid cancer	0.000288	0.00231	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000285	0.00229	CcSEcCtD
Tamoxifen—CYP2E1—thyroid gland—thyroid cancer	0.000285	0.00548	CbGeAlD
Tamoxifen—Dysgeusia—Sorafenib—thyroid cancer	0.000282	0.00227	CcSEcCtD
Tamoxifen—ABCC2—lymph node—thyroid cancer	0.00028	0.00539	CbGeAlD
Tamoxifen—Breast pain—Epirubicin—thyroid cancer	0.000279	0.00224	CcSEcCtD
Tamoxifen—CYP1A1—head—thyroid cancer	0.000277	0.00533	CbGeAlD
Tamoxifen—Cardiovascular disorder—Epirubicin—thyroid cancer	0.000277	0.00223	CcSEcCtD
Tamoxifen—Amenorrhoea—Epirubicin—thyroid cancer	0.000277	0.00223	CcSEcCtD
Tamoxifen—Muscle spasms—Sorafenib—thyroid cancer	0.000277	0.00222	CcSEcCtD
Tamoxifen—Abdominal pain—Vandetanib—thyroid cancer	0.000275	0.00221	CcSEcCtD
Tamoxifen—CYP1B1—lymph node—thyroid cancer	0.000275	0.00528	CbGeAlD
Tamoxifen—CYP2B6—head—thyroid cancer	0.000269	0.00518	CbGeAlD
Tamoxifen—Arthropathy—Epirubicin—thyroid cancer	0.000268	0.00215	CcSEcCtD
Tamoxifen—Liver injury—Doxorubicin—thyroid cancer	0.000268	0.00215	CcSEcCtD
Tamoxifen—Anaemia—Sorafenib—thyroid cancer	0.000266	0.00214	CcSEcCtD
Tamoxifen—Cough increased—Epirubicin—thyroid cancer	0.000266	0.00214	CcSEcCtD
Tamoxifen—Angioedema—Sorafenib—thyroid cancer	0.000263	0.00211	CcSEcCtD
Tamoxifen—Breast pain—Doxorubicin—thyroid cancer	0.000258	0.00207	CcSEcCtD
Tamoxifen—Leukopenia—Sorafenib—thyroid cancer	0.000258	0.00207	CcSEcCtD
Tamoxifen—Blood bilirubin increased—Epirubicin—thyroid cancer	0.000257	0.00207	CcSEcCtD
Tamoxifen—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.000256	0.00206	CcSEcCtD
Tamoxifen—Amenorrhoea—Doxorubicin—thyroid cancer	0.000256	0.00206	CcSEcCtD
Tamoxifen—Creatinine increased—Epirubicin—thyroid cancer	0.000256	0.00205	CcSEcCtD
Tamoxifen—ESR1—lymph node—thyroid cancer	0.000255	0.00491	CbGeAlD
Tamoxifen—Bone pain—Epirubicin—thyroid cancer	0.000254	0.00204	CcSEcCtD
Tamoxifen—CYP2E1—head—thyroid cancer	0.000253	0.00486	CbGeAlD
Tamoxifen—Cough—Sorafenib—thyroid cancer	0.000251	0.00202	CcSEcCtD
Tamoxifen—Inflammation—Epirubicin—thyroid cancer	0.000251	0.00202	CcSEcCtD
Tamoxifen—Asthenia—Vandetanib—thyroid cancer	0.00025	0.00201	CcSEcCtD
Tamoxifen—Gait disturbance—Epirubicin—thyroid cancer	0.000249	0.002	CcSEcCtD
Tamoxifen—Hypertension—Sorafenib—thyroid cancer	0.000249	0.002	CcSEcCtD
Tamoxifen—Arthropathy—Doxorubicin—thyroid cancer	0.000248	0.00199	CcSEcCtD
Tamoxifen—Pruritus—Vandetanib—thyroid cancer	0.000246	0.00198	CcSEcCtD
Tamoxifen—Musculoskeletal pain—Epirubicin—thyroid cancer	0.000246	0.00198	CcSEcCtD
Tamoxifen—Cough increased—Doxorubicin—thyroid cancer	0.000246	0.00198	CcSEcCtD
Tamoxifen—Myalgia—Sorafenib—thyroid cancer	0.000245	0.00197	CcSEcCtD
Tamoxifen—Arthralgia—Sorafenib—thyroid cancer	0.000245	0.00197	CcSEcCtD
Tamoxifen—Vaginal inflammation—Epirubicin—thyroid cancer	0.000243	0.00196	CcSEcCtD
Tamoxifen—Hepatocellular injury—Epirubicin—thyroid cancer	0.000243	0.00196	CcSEcCtD
Tamoxifen—Pulmonary embolism—Epirubicin—thyroid cancer	0.000243	0.00196	CcSEcCtD
Tamoxifen—Dry mouth—Sorafenib—thyroid cancer	0.00024	0.00193	CcSEcCtD
Tamoxifen—Diarrhoea—Vandetanib—thyroid cancer	0.000238	0.00192	CcSEcCtD
Tamoxifen—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.000238	0.00191	CcSEcCtD
Tamoxifen—Creatinine increased—Doxorubicin—thyroid cancer	0.000237	0.0019	CcSEcCtD
Tamoxifen—Bone pain—Doxorubicin—thyroid cancer	0.000235	0.00189	CcSEcCtD
Tamoxifen—Infection—Sorafenib—thyroid cancer	0.000233	0.00188	CcSEcCtD
Tamoxifen—Skin exfoliation—Epirubicin—thyroid cancer	0.000232	0.00187	CcSEcCtD
Tamoxifen—Inflammation—Doxorubicin—thyroid cancer	0.000232	0.00187	CcSEcCtD
Tamoxifen—Fluid retention—Epirubicin—thyroid cancer	0.000231	0.00186	CcSEcCtD
Tamoxifen—Gait disturbance—Doxorubicin—thyroid cancer	0.000231	0.00185	CcSEcCtD
Tamoxifen—Dizziness—Vandetanib—thyroid cancer	0.00023	0.00185	CcSEcCtD
Tamoxifen—Thrombocytopenia—Sorafenib—thyroid cancer	0.00023	0.00185	CcSEcCtD
Tamoxifen—Vaginal infection—Epirubicin—thyroid cancer	0.00023	0.00185	CcSEcCtD
Tamoxifen—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.000228	0.00183	CcSEcCtD
Tamoxifen—Pulmonary embolism—Doxorubicin—thyroid cancer	0.000225	0.00181	CcSEcCtD
Tamoxifen—Vaginal inflammation—Doxorubicin—thyroid cancer	0.000225	0.00181	CcSEcCtD
Tamoxifen—Hepatocellular injury—Doxorubicin—thyroid cancer	0.000225	0.00181	CcSEcCtD
Tamoxifen—Anorexia—Sorafenib—thyroid cancer	0.000224	0.0018	CcSEcCtD
Tamoxifen—Cramps of lower extremities—Epirubicin—thyroid cancer	0.000224	0.0018	CcSEcCtD
Tamoxifen—Vomiting—Vandetanib—thyroid cancer	0.000222	0.00178	CcSEcCtD
Tamoxifen—Neoplasm—Epirubicin—thyroid cancer	0.00022	0.00177	CcSEcCtD
Tamoxifen—Rash—Vandetanib—thyroid cancer	0.00022	0.00176	CcSEcCtD
Tamoxifen—Dermatitis—Vandetanib—thyroid cancer	0.000219	0.00176	CcSEcCtD
Tamoxifen—Headache—Vandetanib—thyroid cancer	0.000218	0.00175	CcSEcCtD
Tamoxifen—Skin exfoliation—Doxorubicin—thyroid cancer	0.000215	0.00173	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000214	0.00172	CcSEcCtD
Tamoxifen—Fluid retention—Doxorubicin—thyroid cancer	0.000214	0.00172	CcSEcCtD
Tamoxifen—Vaginal infection—Doxorubicin—thyroid cancer	0.000213	0.00171	CcSEcCtD
Tamoxifen—Sepsis—Epirubicin—thyroid cancer	0.000211	0.0017	CcSEcCtD
Tamoxifen—Dyspnoea—Sorafenib—thyroid cancer	0.00021	0.00168	CcSEcCtD
Tamoxifen—Nausea—Vandetanib—thyroid cancer	0.000207	0.00166	CcSEcCtD
Tamoxifen—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000207	0.00166	CcSEcCtD
Tamoxifen—Dyspepsia—Sorafenib—thyroid cancer	0.000207	0.00166	CcSEcCtD
Tamoxifen—ABCB1—trachea—thyroid cancer	0.000205	0.00394	CbGeAlD
Tamoxifen—ABCG2—lymph node—thyroid cancer	0.000204	0.00393	CbGeAlD
Tamoxifen—Decreased appetite—Sorafenib—thyroid cancer	0.000204	0.00164	CcSEcCtD
Tamoxifen—Neoplasm—Doxorubicin—thyroid cancer	0.000204	0.00164	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000203	0.00163	CcSEcCtD
Tamoxifen—Fatigue—Sorafenib—thyroid cancer	0.000203	0.00163	CcSEcCtD
Tamoxifen—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000202	0.00162	CcSEcCtD
Tamoxifen—Constipation—Sorafenib—thyroid cancer	0.000201	0.00161	CcSEcCtD
Tamoxifen—Pain—Sorafenib—thyroid cancer	0.000201	0.00161	CcSEcCtD
Tamoxifen—CYP2D6—head—thyroid cancer	0.0002	0.00385	CbGeAlD
Tamoxifen—Hepatic failure—Epirubicin—thyroid cancer	0.000197	0.00158	CcSEcCtD
Tamoxifen—Sepsis—Doxorubicin—thyroid cancer	0.000195	0.00157	CcSEcCtD
Tamoxifen—CYP1A1—lymph node—thyroid cancer	0.000194	0.00373	CbGeAlD
Tamoxifen—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000192	0.00154	CcSEcCtD
Tamoxifen—Hot flush—Epirubicin—thyroid cancer	0.000189	0.00152	CcSEcCtD
Tamoxifen—Menopausal symptoms—Epirubicin—thyroid cancer	0.000187	0.0015	CcSEcCtD
Tamoxifen—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000187	0.0015	CcSEcCtD
Tamoxifen—Urticaria—Sorafenib—thyroid cancer	0.000187	0.0015	CcSEcCtD
Tamoxifen—Abdominal pain—Sorafenib—thyroid cancer	0.000186	0.00149	CcSEcCtD
Tamoxifen—Dermatitis bullous—Epirubicin—thyroid cancer	0.000185	0.00149	CcSEcCtD
Tamoxifen—Hepatic failure—Doxorubicin—thyroid cancer	0.000182	0.00146	CcSEcCtD
Tamoxifen—Osteoarthritis—Epirubicin—thyroid cancer	0.000177	0.00142	CcSEcCtD
Tamoxifen—Hot flush—Doxorubicin—thyroid cancer	0.000175	0.0014	CcSEcCtD
Tamoxifen—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000173	0.00139	CcSEcCtD
Tamoxifen—Hypersensitivity—Sorafenib—thyroid cancer	0.000173	0.00139	CcSEcCtD
Tamoxifen—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000171	0.00137	CcSEcCtD
Tamoxifen—Asthenia—Sorafenib—thyroid cancer	0.000169	0.00135	CcSEcCtD
Tamoxifen—Mood swings—Epirubicin—thyroid cancer	0.000167	0.00134	CcSEcCtD
Tamoxifen—Pruritus—Sorafenib—thyroid cancer	0.000166	0.00134	CcSEcCtD
Tamoxifen—Blood creatinine increased—Epirubicin—thyroid cancer	0.000166	0.00133	CcSEcCtD
Tamoxifen—Osteoarthritis—Doxorubicin—thyroid cancer	0.000164	0.00131	CcSEcCtD
Tamoxifen—Liver function test abnormal—Epirubicin—thyroid cancer	0.000163	0.00131	CcSEcCtD
Tamoxifen—ABCB1—thyroid gland—thyroid cancer	0.000162	0.00312	CbGeAlD
Tamoxifen—Diarrhoea—Sorafenib—thyroid cancer	0.000161	0.00129	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000159	0.00128	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000156	0.00125	CcSEcCtD
Tamoxifen—Dizziness—Sorafenib—thyroid cancer	0.000155	0.00125	CcSEcCtD
Tamoxifen—Mood swings—Doxorubicin—thyroid cancer	0.000155	0.00124	CcSEcCtD
Tamoxifen—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000153	0.00123	CcSEcCtD
Tamoxifen—Influenza—Epirubicin—thyroid cancer	0.000153	0.00123	CcSEcCtD
Tamoxifen—Dysphagia—Epirubicin—thyroid cancer	0.000153	0.00123	CcSEcCtD
Tamoxifen—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000151	0.00121	CcSEcCtD
Tamoxifen—Pancreatitis—Epirubicin—thyroid cancer	0.00015	0.0012	CcSEcCtD
Tamoxifen—Vomiting—Sorafenib—thyroid cancer	0.000149	0.0012	CcSEcCtD
Tamoxifen—Angina pectoris—Epirubicin—thyroid cancer	0.000149	0.0012	CcSEcCtD
Tamoxifen—Rash—Sorafenib—thyroid cancer	0.000148	0.00119	CcSEcCtD
Tamoxifen—Dermatitis—Sorafenib—thyroid cancer	0.000148	0.00119	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000147	0.00118	CcSEcCtD
Tamoxifen—Headache—Sorafenib—thyroid cancer	0.000147	0.00118	CcSEcCtD
Tamoxifen—Bronchitis—Epirubicin—thyroid cancer	0.000147	0.00118	CcSEcCtD
Tamoxifen—Pancytopenia—Epirubicin—thyroid cancer	0.000145	0.00117	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000144	0.00116	CcSEcCtD
Tamoxifen—ABCB1—head—thyroid cancer	0.000144	0.00277	CbGeAlD
Tamoxifen—Neutropenia—Epirubicin—thyroid cancer	0.000143	0.00115	CcSEcCtD
Tamoxifen—Influenza—Doxorubicin—thyroid cancer	0.000141	0.00114	CcSEcCtD
Tamoxifen—Dysphagia—Doxorubicin—thyroid cancer	0.000141	0.00114	CcSEcCtD
Tamoxifen—Nausea—Sorafenib—thyroid cancer	0.00014	0.00112	CcSEcCtD
Tamoxifen—Weight increased—Epirubicin—thyroid cancer	0.000139	0.00112	CcSEcCtD
Tamoxifen—Pancreatitis—Doxorubicin—thyroid cancer	0.000139	0.00111	CcSEcCtD
Tamoxifen—Weight decreased—Epirubicin—thyroid cancer	0.000138	0.00111	CcSEcCtD
Tamoxifen—Angina pectoris—Doxorubicin—thyroid cancer	0.000138	0.00111	CcSEcCtD
Tamoxifen—Pneumonia—Epirubicin—thyroid cancer	0.000137	0.0011	CcSEcCtD
Tamoxifen—Bronchitis—Doxorubicin—thyroid cancer	0.000136	0.00109	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000135	0.00108	CcSEcCtD
Tamoxifen—Pancytopenia—Doxorubicin—thyroid cancer	0.000134	0.00108	CcSEcCtD
Tamoxifen—Urinary tract infection—Epirubicin—thyroid cancer	0.000132	0.00106	CcSEcCtD
Tamoxifen—Neutropenia—Doxorubicin—thyroid cancer	0.000132	0.00106	CcSEcCtD
Tamoxifen—Sweating—Epirubicin—thyroid cancer	0.000131	0.00105	CcSEcCtD
Tamoxifen—Weight increased—Doxorubicin—thyroid cancer	0.000129	0.00103	CcSEcCtD
Tamoxifen—Weight decreased—Doxorubicin—thyroid cancer	0.000128	0.00103	CcSEcCtD
Tamoxifen—Sinusitis—Epirubicin—thyroid cancer	0.000128	0.00103	CcSEcCtD
Tamoxifen—Pneumonia—Doxorubicin—thyroid cancer	0.000127	0.00102	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000125	0.001	CcSEcCtD
Tamoxifen—Haemoglobin—Epirubicin—thyroid cancer	0.000123	0.000987	CcSEcCtD
Tamoxifen—Urinary tract infection—Doxorubicin—thyroid cancer	0.000122	0.000984	CcSEcCtD
Tamoxifen—Haemorrhage—Epirubicin—thyroid cancer	0.000122	0.000982	CcSEcCtD
Tamoxifen—Hepatitis—Epirubicin—thyroid cancer	0.000122	0.000982	CcSEcCtD
Tamoxifen—Hypoaesthesia—Epirubicin—thyroid cancer	0.000122	0.000977	CcSEcCtD
Tamoxifen—Pharyngitis—Epirubicin—thyroid cancer	0.000121	0.000975	CcSEcCtD
Tamoxifen—Sweating—Doxorubicin—thyroid cancer	0.000121	0.000971	CcSEcCtD
Tamoxifen—Oedema peripheral—Epirubicin—thyroid cancer	0.00012	0.000968	CcSEcCtD
Tamoxifen—Sinusitis—Doxorubicin—thyroid cancer	0.000118	0.00095	CcSEcCtD
Tamoxifen—Visual impairment—Epirubicin—thyroid cancer	0.000118	0.000947	CcSEcCtD
Tamoxifen—Erythema multiforme—Epirubicin—thyroid cancer	0.000116	0.000929	CcSEcCtD
Tamoxifen—Haemoglobin—Doxorubicin—thyroid cancer	0.000114	0.000913	CcSEcCtD
Tamoxifen—Flushing—Epirubicin—thyroid cancer	0.000113	0.000912	CcSEcCtD
Tamoxifen—Haemorrhage—Doxorubicin—thyroid cancer	0.000113	0.000909	CcSEcCtD
Tamoxifen—Hepatitis—Doxorubicin—thyroid cancer	0.000113	0.000909	CcSEcCtD
Tamoxifen—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000113	0.000904	CcSEcCtD
Tamoxifen—Pharyngitis—Doxorubicin—thyroid cancer	0.000112	0.000902	CcSEcCtD
Tamoxifen—Oedema peripheral—Doxorubicin—thyroid cancer	0.000111	0.000895	CcSEcCtD
Tamoxifen—Arrhythmia—Epirubicin—thyroid cancer	0.000109	0.000877	CcSEcCtD
Tamoxifen—Visual impairment—Doxorubicin—thyroid cancer	0.000109	0.000876	CcSEcCtD
Tamoxifen—Alopecia—Epirubicin—thyroid cancer	0.000108	0.000868	CcSEcCtD
Tamoxifen—Erythema multiforme—Doxorubicin—thyroid cancer	0.000107	0.000859	CcSEcCtD
Tamoxifen—Erythema—Epirubicin—thyroid cancer	0.000106	0.000855	CcSEcCtD
Tamoxifen—Flushing—Doxorubicin—thyroid cancer	0.000105	0.000843	CcSEcCtD
Tamoxifen—Dysgeusia—Epirubicin—thyroid cancer	0.000104	0.000837	CcSEcCtD
Tamoxifen—Back pain—Epirubicin—thyroid cancer	0.000103	0.000827	CcSEcCtD
Tamoxifen—Muscle spasms—Epirubicin—thyroid cancer	0.000102	0.000822	CcSEcCtD
Tamoxifen—Arrhythmia—Doxorubicin—thyroid cancer	0.000101	0.000812	CcSEcCtD
Tamoxifen—ABCB1—lymph node—thyroid cancer	0.000101	0.00194	CbGeAlD
Tamoxifen—Alopecia—Doxorubicin—thyroid cancer	0.0001	0.000803	CcSEcCtD
Tamoxifen—Erythema—Doxorubicin—thyroid cancer	9.85e-05	0.000791	CcSEcCtD
Tamoxifen—Anaemia—Epirubicin—thyroid cancer	9.84e-05	0.00079	CcSEcCtD
Tamoxifen—Dysgeusia—Doxorubicin—thyroid cancer	9.64e-05	0.000775	CcSEcCtD
Tamoxifen—Leukopenia—Epirubicin—thyroid cancer	9.53e-05	0.000765	CcSEcCtD
Tamoxifen—Back pain—Doxorubicin—thyroid cancer	9.53e-05	0.000765	CcSEcCtD
Tamoxifen—Muscle spasms—Doxorubicin—thyroid cancer	9.47e-05	0.000761	CcSEcCtD
Tamoxifen—Cough—Epirubicin—thyroid cancer	9.29e-05	0.000746	CcSEcCtD
Tamoxifen—Hypertension—Epirubicin—thyroid cancer	9.19e-05	0.000738	CcSEcCtD
Tamoxifen—Anaemia—Doxorubicin—thyroid cancer	9.1e-05	0.000731	CcSEcCtD
Tamoxifen—Arthralgia—Epirubicin—thyroid cancer	9.06e-05	0.000728	CcSEcCtD
Tamoxifen—Chest pain—Epirubicin—thyroid cancer	9.06e-05	0.000728	CcSEcCtD
Tamoxifen—Myalgia—Epirubicin—thyroid cancer	9.06e-05	0.000728	CcSEcCtD
Tamoxifen—Anxiety—Epirubicin—thyroid cancer	9.03e-05	0.000725	CcSEcCtD
Tamoxifen—Discomfort—Epirubicin—thyroid cancer	8.95e-05	0.000719	CcSEcCtD
Tamoxifen—Dry mouth—Epirubicin—thyroid cancer	8.86e-05	0.000712	CcSEcCtD
Tamoxifen—Leukopenia—Doxorubicin—thyroid cancer	8.81e-05	0.000708	CcSEcCtD
Tamoxifen—Oedema—Epirubicin—thyroid cancer	8.69e-05	0.000698	CcSEcCtD
Tamoxifen—Infection—Epirubicin—thyroid cancer	8.63e-05	0.000693	CcSEcCtD
Tamoxifen—Cough—Doxorubicin—thyroid cancer	8.59e-05	0.00069	CcSEcCtD
Tamoxifen—Thrombocytopenia—Epirubicin—thyroid cancer	8.5e-05	0.000683	CcSEcCtD
Tamoxifen—Hypertension—Doxorubicin—thyroid cancer	8.5e-05	0.000683	CcSEcCtD
Tamoxifen—Hyperhidrosis—Epirubicin—thyroid cancer	8.4e-05	0.000675	CcSEcCtD
Tamoxifen—Arthralgia—Doxorubicin—thyroid cancer	8.38e-05	0.000674	CcSEcCtD
Tamoxifen—Chest pain—Doxorubicin—thyroid cancer	8.38e-05	0.000674	CcSEcCtD
Tamoxifen—Myalgia—Doxorubicin—thyroid cancer	8.38e-05	0.000674	CcSEcCtD
Tamoxifen—Anxiety—Doxorubicin—thyroid cancer	8.35e-05	0.000671	CcSEcCtD
Tamoxifen—Discomfort—Doxorubicin—thyroid cancer	8.28e-05	0.000665	CcSEcCtD
Tamoxifen—Anorexia—Epirubicin—thyroid cancer	8.28e-05	0.000665	CcSEcCtD
Tamoxifen—Dry mouth—Doxorubicin—thyroid cancer	8.2e-05	0.000659	CcSEcCtD
Tamoxifen—Oedema—Doxorubicin—thyroid cancer	8.04e-05	0.000646	CcSEcCtD
Tamoxifen—Infection—Doxorubicin—thyroid cancer	7.98e-05	0.000641	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Epirubicin—thyroid cancer	7.91e-05	0.000636	CcSEcCtD
Tamoxifen—Thrombocytopenia—Doxorubicin—thyroid cancer	7.87e-05	0.000632	CcSEcCtD
Tamoxifen—Insomnia—Epirubicin—thyroid cancer	7.86e-05	0.000631	CcSEcCtD
Tamoxifen—Paraesthesia—Epirubicin—thyroid cancer	7.8e-05	0.000627	CcSEcCtD
Tamoxifen—Hyperhidrosis—Doxorubicin—thyroid cancer	7.77e-05	0.000624	CcSEcCtD
Tamoxifen—Dyspnoea—Epirubicin—thyroid cancer	7.74e-05	0.000622	CcSEcCtD
Tamoxifen—Anorexia—Doxorubicin—thyroid cancer	7.66e-05	0.000615	CcSEcCtD
Tamoxifen—Dyspepsia—Epirubicin—thyroid cancer	7.65e-05	0.000614	CcSEcCtD
Tamoxifen—Decreased appetite—Epirubicin—thyroid cancer	7.55e-05	0.000607	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Epirubicin—thyroid cancer	7.5e-05	0.000602	CcSEcCtD
Tamoxifen—Fatigue—Epirubicin—thyroid cancer	7.49e-05	0.000602	CcSEcCtD
Tamoxifen—Pain—Epirubicin—thyroid cancer	7.43e-05	0.000597	CcSEcCtD
Tamoxifen—Constipation—Epirubicin—thyroid cancer	7.43e-05	0.000597	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	7.32e-05	0.000588	CcSEcCtD
Tamoxifen—Insomnia—Doxorubicin—thyroid cancer	7.27e-05	0.000584	CcSEcCtD
Tamoxifen—Paraesthesia—Doxorubicin—thyroid cancer	7.22e-05	0.00058	CcSEcCtD
Tamoxifen—Dyspnoea—Doxorubicin—thyroid cancer	7.17e-05	0.000576	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Epirubicin—thyroid cancer	7.1e-05	0.000571	CcSEcCtD
Tamoxifen—Dyspepsia—Doxorubicin—thyroid cancer	7.07e-05	0.000568	CcSEcCtD
Tamoxifen—Decreased appetite—Doxorubicin—thyroid cancer	6.99e-05	0.000561	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Doxorubicin—thyroid cancer	6.94e-05	0.000557	CcSEcCtD
Tamoxifen—Fatigue—Doxorubicin—thyroid cancer	6.93e-05	0.000557	CcSEcCtD
Tamoxifen—Urticaria—Epirubicin—thyroid cancer	6.9e-05	0.000554	CcSEcCtD
Tamoxifen—Pain—Doxorubicin—thyroid cancer	6.87e-05	0.000552	CcSEcCtD
Tamoxifen—Constipation—Doxorubicin—thyroid cancer	6.87e-05	0.000552	CcSEcCtD
Tamoxifen—Abdominal pain—Epirubicin—thyroid cancer	6.87e-05	0.000552	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Doxorubicin—thyroid cancer	6.57e-05	0.000528	CcSEcCtD
Tamoxifen—Hypersensitivity—Epirubicin—thyroid cancer	6.4e-05	0.000514	CcSEcCtD
Tamoxifen—Urticaria—Doxorubicin—thyroid cancer	6.38e-05	0.000513	CcSEcCtD
Tamoxifen—Abdominal pain—Doxorubicin—thyroid cancer	6.35e-05	0.00051	CcSEcCtD
Tamoxifen—Asthenia—Epirubicin—thyroid cancer	6.23e-05	0.000501	CcSEcCtD
Tamoxifen—Pruritus—Epirubicin—thyroid cancer	6.15e-05	0.000494	CcSEcCtD
Tamoxifen—Diarrhoea—Epirubicin—thyroid cancer	5.94e-05	0.000477	CcSEcCtD
Tamoxifen—Hypersensitivity—Doxorubicin—thyroid cancer	5.92e-05	0.000476	CcSEcCtD
Tamoxifen—Asthenia—Doxorubicin—thyroid cancer	5.77e-05	0.000463	CcSEcCtD
Tamoxifen—Dizziness—Epirubicin—thyroid cancer	5.74e-05	0.000461	CcSEcCtD
Tamoxifen—Pruritus—Doxorubicin—thyroid cancer	5.69e-05	0.000457	CcSEcCtD
Tamoxifen—Vomiting—Epirubicin—thyroid cancer	5.52e-05	0.000444	CcSEcCtD
Tamoxifen—Diarrhoea—Doxorubicin—thyroid cancer	5.5e-05	0.000442	CcSEcCtD
Tamoxifen—Rash—Epirubicin—thyroid cancer	5.48e-05	0.00044	CcSEcCtD
Tamoxifen—Dermatitis—Epirubicin—thyroid cancer	5.47e-05	0.00044	CcSEcCtD
Tamoxifen—Headache—Epirubicin—thyroid cancer	5.44e-05	0.000437	CcSEcCtD
Tamoxifen—Dizziness—Doxorubicin—thyroid cancer	5.31e-05	0.000427	CcSEcCtD
Tamoxifen—Nausea—Epirubicin—thyroid cancer	5.16e-05	0.000414	CcSEcCtD
Tamoxifen—Vomiting—Doxorubicin—thyroid cancer	5.11e-05	0.000411	CcSEcCtD
Tamoxifen—Rash—Doxorubicin—thyroid cancer	5.07e-05	0.000407	CcSEcCtD
Tamoxifen—Dermatitis—Doxorubicin—thyroid cancer	5.06e-05	0.000407	CcSEcCtD
Tamoxifen—Headache—Doxorubicin—thyroid cancer	5.03e-05	0.000404	CcSEcCtD
Tamoxifen—Nausea—Doxorubicin—thyroid cancer	4.77e-05	0.000384	CcSEcCtD
Tamoxifen—ESR1—Gene Expression—MEN1—thyroid cancer	2.21e-05	0.000311	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	2.2e-05	0.00031	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—RXRA—thyroid cancer	2.19e-05	0.000308	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CHST14—thyroid cancer	2.14e-05	0.000301	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—HPGD—thyroid cancer	2.11e-05	0.000296	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—HRAS—thyroid cancer	2.1e-05	0.000295	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NDUFA13—thyroid cancer	2.09e-05	0.000294	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CHST14—thyroid cancer	2.09e-05	0.000294	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TCF7L1—thyroid cancer	2.09e-05	0.000294	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MINPP1—thyroid cancer	2.08e-05	0.000293	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	2.08e-05	0.000292	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NDUFA13—thyroid cancer	2.07e-05	0.000292	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	2.06e-05	0.00029	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.06e-05	0.00029	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.05e-05	0.000289	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—PTEN—thyroid cancer	2.05e-05	0.000288	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—TPR—thyroid cancer	2.04e-05	0.000287	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.03e-05	0.000286	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—SLC5A5—thyroid cancer	2.02e-05	0.000285	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—PTEN—thyroid cancer	2.01e-05	0.000283	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PRKAR1A—thyroid cancer	2.01e-05	0.000282	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CHST14—thyroid cancer	1.97e-05	0.000277	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—TPR—thyroid cancer	1.96e-05	0.000276	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CHST14—thyroid cancer	1.95e-05	0.000274	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—PTEN—thyroid cancer	1.94e-05	0.000273	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—PPARG—thyroid cancer	1.94e-05	0.000273	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PRKAR1A—thyroid cancer	1.93e-05	0.000272	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—HPGD—thyroid cancer	1.93e-05	0.000272	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PTGS2—thyroid cancer	1.91e-05	0.000269	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.91e-05	0.000269	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.9e-05	0.000267	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	1.86e-05	0.000262	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—AKT1—thyroid cancer	1.85e-05	0.00026	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—PPARG—thyroid cancer	1.85e-05	0.00026	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.83e-05	0.000257	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.82e-05	0.000256	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—TPR—thyroid cancer	1.79e-05	0.000251	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PTGS2—thyroid cancer	1.78e-05	0.00025	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NDUFA13—thyroid cancer	1.77e-05	0.000249	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—TPR—thyroid cancer	1.77e-05	0.000249	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PRKAR1A—thyroid cancer	1.76e-05	0.000247	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.75e-05	0.000246	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	1.74e-05	0.000245	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PPARG—thyroid cancer	1.74e-05	0.000245	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—HPGD—thyroid cancer	1.72e-05	0.000243	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.71e-05	0.00024	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—RXRA—thyroid cancer	1.7e-05	0.000239	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—HPGD—thyroid cancer	1.68e-05	0.000237	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PTEN—thyroid cancer	1.67e-05	0.000235	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CHST14—thyroid cancer	1.67e-05	0.000234	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.65e-05	0.000233	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—TPR—thyroid cancer	1.62e-05	0.000228	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.62e-05	0.000228	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.61e-05	0.000226	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	1.6e-05	0.000225	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—HPGD—thyroid cancer	1.59e-05	0.000223	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HPGD—thyroid cancer	1.57e-05	0.000221	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.57e-05	0.00022	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PTEN—thyroid cancer	1.55e-05	0.000218	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.54e-05	0.000217	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.54e-05	0.000217	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—SLC5A5—thyroid cancer	1.53e-05	0.000215	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TSHR—thyroid cancer	1.53e-05	0.000215	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PRKAR1A—thyroid cancer	1.5e-05	0.000211	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—RXRA—thyroid cancer	1.48e-05	0.000208	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—SLC5A5—thyroid cancer	1.47e-05	0.000207	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.47e-05	0.000206	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PPARG—thyroid cancer	1.46e-05	0.000205	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MEN1—thyroid cancer	1.44e-05	0.000202	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.43e-05	0.000201	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.42e-05	0.000199	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.4e-05	0.000197	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.38e-05	0.000194	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.37e-05	0.000192	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PTGS2—thyroid cancer	1.37e-05	0.000192	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HPGD—thyroid cancer	1.34e-05	0.000189	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—SLC5A5—thyroid cancer	1.34e-05	0.000188	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.33e-05	0.000187	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—TPR—thyroid cancer	1.31e-05	0.000184	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTCH1—thyroid cancer	1.3e-05	0.000183	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.3e-05	0.000183	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	1.29e-05	0.000181	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CHST14—thyroid cancer	1.29e-05	0.000181	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—TPR—thyroid cancer	1.28e-05	0.000181	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—RXRA—thyroid cancer	1.28e-05	0.000181	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—TPR—thyroid cancer	1.28e-05	0.00018	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.28e-05	0.000179	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	1.26e-05	0.000178	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.26e-05	0.000177	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.25e-05	0.000176	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—RXRA—thyroid cancer	1.24e-05	0.000174	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—SLC5A5—thyroid cancer	1.22e-05	0.000171	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—TPR—thyroid cancer	1.21e-05	0.00017	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.2e-05	0.000169	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PTEN—thyroid cancer	1.19e-05	0.000168	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	1.19e-05	0.000167	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SST—thyroid cancer	1.19e-05	0.000167	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—AKT1—thyroid cancer	1.18e-05	0.000166	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—AKT1—thyroid cancer	1.16e-05	0.000163	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—AKT1—thyroid cancer	1.15e-05	0.000162	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PTGS2—thyroid cancer	1.15e-05	0.000161	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CALCA—thyroid cancer	1.14e-05	0.000161	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—RXRA—thyroid cancer	1.12e-05	0.000158	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—AKT1—thyroid cancer	1.12e-05	0.000157	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—RXRA—thyroid cancer	1.11e-05	0.000157	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—TPR—thyroid cancer	1.11e-05	0.000156	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.09e-05	0.000154	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.09e-05	0.000153	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.09e-05	0.000153	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.08e-05	0.000152	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PPARG—thyroid cancer	1.07e-05	0.000151	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HPGD—thyroid cancer	1.04e-05	0.000146	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDK1—thyroid cancer	1.03e-05	0.000146	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—RXRA—thyroid cancer	1.02e-05	0.000144	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PTEN—thyroid cancer	9.99e-06	0.000141	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—TPR—thyroid cancer	9.9e-06	0.000139	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.89e-06	0.000139	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—SLC5A5—thyroid cancer	9.81e-06	0.000138	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	9.74e-06	0.000137	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—TPR—thyroid cancer	9.66e-06	0.000136	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	9.66e-06	0.000136	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—AKT1—thyroid cancer	9.61e-06	0.000135	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—SLC5A5—thyroid cancer	9.61e-06	0.000135	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—SLC5A5—thyroid cancer	9.59e-06	0.000135	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PRKAR1A—thyroid cancer	9.51e-06	0.000134	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—PPARG—thyroid cancer	9.33e-06	0.000131	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—TPR—thyroid cancer	9.11e-06	0.000128	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—SLC5A5—thyroid cancer	9.06e-06	0.000127	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—TPR—thyroid cancer	9.03e-06	0.000127	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	8.96e-06	0.000126	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—AKT1—thyroid cancer	8.94e-06	0.000126	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	8.88e-06	0.000125	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.83e-06	0.000124	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.49e-06	0.000119	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTGS2—thyroid cancer	8.45e-06	0.000119	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NRG1—thyroid cancer	8.31e-06	0.000117	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SLC5A5—thyroid cancer	8.3e-06	0.000117	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—RXRA—thyroid cancer	8.24e-06	0.000116	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	8.16e-06	0.000115	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PPARG—thyroid cancer	8.1e-06	0.000114	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—RXRA—thyroid cancer	8.07e-06	0.000114	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—RXRA—thyroid cancer	8.06e-06	0.000113	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.05e-06	0.000113	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PPARG—thyroid cancer	7.8e-06	0.00011	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.78e-06	0.000109	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—TPR—thyroid cancer	7.72e-06	0.000109	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—RXRA—thyroid cancer	7.61e-06	0.000107	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	7.59e-06	0.000107	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TERT—thyroid cancer	7.46e-06	0.000105	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SLC5A5—thyroid cancer	7.41e-06	0.000104	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.4e-06	0.000104	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTEN—thyroid cancer	7.37e-06	0.000104	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—AKT1—thyroid cancer	7.31e-06	0.000103	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SLC5A5—thyroid cancer	7.23e-06	0.000102	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HIF1A—thyroid cancer	7.13e-06	0.0001	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PPARG—thyroid cancer	7.1e-06	9.99e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PPARG—thyroid cancer	7.04e-06	9.9e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—RXRA—thyroid cancer	6.98e-06	9.82e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.95e-06	9.77e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.88e-06	9.68e-05	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—AKT1—thyroid cancer	6.87e-06	9.67e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SLC5A5—thyroid cancer	6.82e-06	9.59e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.79e-06	9.55e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SLC5A5—thyroid cancer	6.76e-06	9.51e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PPARG—thyroid cancer	6.45e-06	9.07e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—thyroid cancer	6.37e-06	8.97e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.33e-06	8.91e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—RXRA—thyroid cancer	6.23e-06	8.76e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—thyroid cancer	6.14e-06	8.63e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—RXRA—thyroid cancer	6.08e-06	8.55e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.06e-06	8.52e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TPR—thyroid cancer	5.95e-06	8.38e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—BRAF—thyroid cancer	5.91e-06	8.31e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	5.86e-06	8.24e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC5A5—thyroid cancer	5.78e-06	8.12e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—thyroid cancer	5.76e-06	8.1e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—RXRA—thyroid cancer	5.73e-06	8.06e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—RXRA—thyroid cancer	5.68e-06	7.99e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—thyroid cancer	5.58e-06	7.86e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTEN—thyroid cancer	5.56e-06	7.82e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—thyroid cancer	5.54e-06	7.79e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.52e-06	7.77e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.41e-06	7.61e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTEN—thyroid cancer	5.35e-06	7.53e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARG—thyroid cancer	5.2e-06	7.32e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARG—thyroid cancer	5.1e-06	7.17e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARG—thyroid cancer	5.09e-06	7.15e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—thyroid cancer	5.07e-06	7.14e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTEN—thyroid cancer	4.87e-06	6.85e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—RXRA—thyroid cancer	4.85e-06	6.83e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTEN—thyroid cancer	4.83e-06	6.79e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARG—thyroid cancer	4.81e-06	6.76e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.72e-06	6.64e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC5A5—thyroid cancer	4.46e-06	6.27e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTEN—thyroid cancer	4.42e-06	6.22e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARG—thyroid cancer	4.41e-06	6.2e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—thyroid cancer	4.31e-06	6.06e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—thyroid cancer	4.25e-06	5.97e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTEN—thyroid cancer	4.16e-06	5.85e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—thyroid cancer	4.09e-06	5.76e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—thyroid cancer	4.01e-06	5.64e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—thyroid cancer	4e-06	5.63e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARG—thyroid cancer	3.93e-06	5.53e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARG—thyroid cancer	3.84e-06	5.4e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—thyroid cancer	3.78e-06	5.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—RXRA—thyroid cancer	3.75e-06	5.27e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NRAS—thyroid cancer	3.71e-06	5.22e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—thyroid cancer	3.69e-06	5.19e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARG—thyroid cancer	3.62e-06	5.09e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARG—thyroid cancer	3.59e-06	5.04e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTEN—thyroid cancer	3.57e-06	5.02e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTEN—thyroid cancer	3.5e-06	4.92e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTEN—thyroid cancer	3.49e-06	4.91e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—thyroid cancer	3.47e-06	4.88e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTEN—thyroid cancer	3.3e-06	4.64e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—thyroid cancer	3.2e-06	4.51e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—thyroid cancer	3.2e-06	4.49e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—thyroid cancer	3.09e-06	4.35e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—thyroid cancer	3.08e-06	4.34e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARG—thyroid cancer	3.06e-06	4.31e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTEN—thyroid cancer	3.02e-06	4.25e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—thyroid cancer	3.02e-06	4.25e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—thyroid cancer	2.85e-06	4e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—thyroid cancer	2.84e-06	3.99e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—thyroid cancer	2.82e-06	3.97e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—thyroid cancer	2.81e-06	3.95e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—thyroid cancer	2.78e-06	3.91e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—thyroid cancer	2.72e-06	3.82e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTEN—thyroid cancer	2.7e-06	3.79e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTEN—thyroid cancer	2.63e-06	3.7e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—thyroid cancer	2.55e-06	3.59e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTEN—thyroid cancer	2.48e-06	3.49e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTEN—thyroid cancer	2.46e-06	3.46e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—thyroid cancer	2.41e-06	3.39e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—thyroid cancer	2.4e-06	3.37e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARG—thyroid cancer	2.36e-06	3.33e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTEN—thyroid cancer	2.1e-06	2.96e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—thyroid cancer	2.06e-06	2.89e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—thyroid cancer	2.02e-06	2.83e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—thyroid cancer	2.01e-06	2.83e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—thyroid cancer	1.9e-06	2.67e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.86e-06	2.62e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—thyroid cancer	1.74e-06	2.45e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTEN—thyroid cancer	1.62e-06	2.28e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—thyroid cancer	1.55e-06	2.19e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—thyroid cancer	1.52e-06	2.13e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—thyroid cancer	1.43e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—thyroid cancer	1.42e-06	1.99e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—thyroid cancer	1.21e-06	1.7e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—thyroid cancer	9.35e-07	1.32e-05	CbGpPWpGaD
